recurrent malignant solid neoplasm

Showing 26 - 50 of 50

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +124 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +30 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +123 more
Aug 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Best Practice, Educational Intervention,

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Malignant Solid Neoplasm
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Adoption of Audio Recording in Outpatient Supportive Care Center

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Communication Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Best Practice
  • +6 more
  • (no location specified)
Jul 12, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

Active, not recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +19 more
Jun 29, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Solid Tumor Trial

Withdrawn
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • (no location specified)
May 24, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Recurrent Malignant Solid Tumor, Recurrent Osteosarcoma, Refractory Malignant Solid Tumor Trial in United States (Laboratory

Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +23 more
Apr 22, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Hematopoietic and Lymphoid Cell Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Puerto Rico,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Educational Intervention
  • +3 more
  • Fairbanks, Alaska
  • +152 more
Mar 29, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Placebo

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Placebo Administration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,

Recruiting
  • Advanced Adenocarcinoma
  • +5 more
  • Antineoplastic Vaccine
  • Sargramostim
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 29, 2021

Frequency of Cachexia in Ambulatory Cancer Patients and

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 1, 2021

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston

Recruiting
  • Recurrent Cutaneous Melanoma
  • +27 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

Completed
  • Childhood Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +20 more
Apr 12, 2021

Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,

Completed
  • Adult Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +21 more
Mar 1, 2021